user

ELEVATE: Study design of the observational study of bimekizumab in adult patients with moderate to severe plaque psoriasis

被引：0
|
作者：
Asadullah, Khusru [1 ,2 ]
Stavermann, Thomas [3 ]
Heidbrede, Tanja [4 ]
Schlueter, Kathrin [5 ]
Fierens, Frederik [6 ]
Thaci, Diamant [7 ]
von Kiedrowski, Ralph Michael [8 ]
机构：
[1] Hautarztpraxis, Potsdam, Germany
[2] Hautklin Charite, Berlin, Germany
[3] MVZ Hautzentrum Gropiuspas GmbH, Berlin, Germany
[4] UCB BioSci GmbH, Monheim, Germany
[5] UCB Pharma GmbH, Monheim, Germany
[6] UCB Pharma srl, Brussels, Belgium
[7] Univ Klinikum Schleswig Holstein, Inst Entzundungsmed, Campus Lubeck, Lubeck, Germany
[8] CMS3 GmbH, Selters, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P116
引用
收藏
页码：81 / 82
页数：2
相关论文
共 50 条
  • [1] Bimekizumab treatment in patients with moderate to severe plaque psoriasis: a drug safety evaluation
    Ruggiero, Angelo
    Potestio, Luca
    Martora, Fabrizio
    Villani, Alessia
    Comune, Rosita
    Megna, Matteo
    [J]. EXPERT OPINION ON DRUG SAFETY, 2023, 22 (05) : 355 - 362
  • [2] Bimekizumab efficacy in subgroups defined by prior systemic treatment in patients with moderate to severe plaque psoriasis
    Rosmarin, David
    Lebwohl, Mark
    Feldman, Steven R.
    Staubach-Renz, Petra
    Davis, Leah
    Wixted, Krista
    Madden, Cynthia
    Gomez, Natalie Nunez
    Pinter, Andreas
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB146 - AB146
  • [3] COST-EFFECTIVENESS ANALYSIS OF BIMEKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS IN GREECE
    Koulentaki, M.
    Tzanetakos, C.
    Stratigos, A.
    Sotiriou, E.
    Ladha, I
    Christou, P.
    Relakis, J.
    Kourlaba, G.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S74 - S74
  • [4] Bimekizumab in moderate-to-severe plaque psoriasis: population pharmacokinetic and pharmacodynamic relationships
    Vajjah, P.
    Acharya, C.
    Brekkan, A.
    Zamacona, M.
    Nemansky, M.
    Peterson, L.
    MacPherson, M.
    Oliver, R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E47 - E48
  • [5] BUDGET IMPACT ANALYSIS OF BIMEKIZUMAB FOR THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN GREECE
    Koulentaki, M.
    Tzanetakos, C.
    Stratigos, A.
    Sotiriou, E.
    Ladha, I
    Kountouris, V
    Relakis, J.
    Kourlaba, G.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S185 - S185
  • [6] Bimekizumab in patients with moderate-to-severe plaque psoriasis by bodyweight: pooled results from phase III trials
    Pinter, A.
    Strober, B.
    Rosmarin, D.
    Gisondi, P.
    Vanvoorden, V.
    Peterson, L.
    Madden, C.
    de Cuyper, D.
    Warren, R.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E48 - E49
  • [7] Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque Psoriasis
    Ma, Guangli
    Xie, Rujia
    Strober, Bruce
    Langley, Richard
    Ito, Kaori
    Krishnaswami, Sriram
    Wolk, Robert
    Valdez, Hernan
    Rottinghaus, Scott
    Tallman, Anna
    Gupta, Pankaj
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (06): : 587 - 596
  • [8] Bimekizumab efficacy and safety in Korean patients with moderate to severe plaque psoriasis: A phase 3, randomized, placebo-controlled, double-blinded study
    Youn, Sang Woong
    Jo, Seong Jin
    Park, Chul Jong
    Kim, Dong Hyun
    Shin, Bong Seok
    Jeong, Ki Heon
    Bang, Chul Hwan
    Cross, Nancy
    Thirlwell, Jackie
    Hoepken, Bengt
    [J]. JOURNAL OF DERMATOLOGY, 2024,
  • [9] Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
    Chiricozzi, Andrea
    Burlando, Martina
    Caldarola, Giacomo
    Conti, Andrea
    Damiani, Giovanni
    De Simone, Clara
    Dini, Valentina
    Malagoli, Piergiorgio
    Peccerillo, Francesca
    Potenza, Concetta
    Scala, Emanuele
    Skroza, Nevena
    Balato, Anna
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (03) : 441 - 447
  • [10] Ixekizumab Effectiveness and Safety in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Multicenter, Retrospective Observational Study
    Andrea Chiricozzi
    Martina Burlando
    Giacomo Caldarola
    Andrea Conti
    Giovanni Damiani
    Clara De Simone
    Valentina Dini
    Piergiorgio Malagoli
    Francesca Peccerillo
    Concetta Potenza
    Emanuele Scala
    Nevena Skroza
    Anna Balato
    [J]. American Journal of Clinical Dermatology, 2020, 21 : 441 - 447
12345